A discussion on how to use AI and bioinformatics to find candidate drugs for repurposing to meet the challenges of COVID-19. Identifying existing drugs currently on the market to treat a variety of conditions that could also be used to treat COVID-19 offers an opportunity to quickly meet an urgent need, since existing drugs have already completed extensive trials and are available in the market.
Quickly knowing which drugs could be effective in the fight against COVID-19, and what side effects could be expected, is vital, but the number of drugs on the market is vast. This discussion examines the role AI and bioinformatics can play in finding rapid solutions to a rapidly spreading healthcare crisis.
Speakers:
- Dr. Prasanna R Kolatkar, Senior Scientist at Qatar Biomedical Research Institute, Hamad Bin Khalifa University
- Dr. Raghvendra Mall, Scientist at Qatar Computing Research Institute, Hamad Bin Khalifa University
- Maha El Akoum, Head of Content at WISH
- Professor Aziz Sheikh, Director at Usher Institute